Table 1.
Baseline patient and pathological characteristics modified from reference 6
| Characteristic | Short (%) | Long (%) | P-valuea |
|---|---|---|---|
| Gender | |||
| Male | 14 (61) | 13 (68) | |
| Female | 9 (39) | 6 (32) | 0.75 |
| Breslow thickness (mm) | |||
| Mean + SD | 4.9 + 6.1 | 1.9 + 1.6 | 0.016 |
| Ulceration | |||
| Present | 15 (65) | 3 (16) | |
| Absent | 8 (35) | 16 (84) | 0.002 |
| Number of metastatic nodes | |||
| 1 | 5 (22) | 13 (68) | |
| 2-3 | 14 (61) | 3 (16) | |
| > 4 | 4 (17) | 3 (16) | 0.005 |
| Mutation status: | |||
| BRAF mutated | 0.13 | ||
| V600E | 12(52) | 6 (32) | |
| V600 K | 1 (4) | − | |
| BRAF wildtype | 10 (43) | 13 (68) | |
a P-values calculated using Fisher’s exact test for categorical data and Mann-Whitney test for continuous data